NASDAQ: CTMXCytomx Therapeutics Inc Stock Ownership - Who owns Cytomx Therapeutics?
Insider buying vs selling
Have Cytomx Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Christopher Ogden | Chief Financial Officer | 2026-06-15 | 1,624 | $3.05 | $4.95kSell |
| Marcia Belvin | SVP Chief Scientific Officer | 2026-03-17 | 31,492 | $6.42 | $202.27kSell |
| Yuwaye Chu | Chief Medical Officer | 2026-03-17 | 21,279 | $6.42 | $136.68kSell |
| Sean A. McCarthy | CEO | 2026-03-17 | 118,969 | $6.42 | $764.14kSell |
| Christopher Ogden | Chief Financial Officer | 2026-03-17 | 19,323 | $6.42 | $124.11kSell |
| Sean A. McCarthy | CEO | 2025-11-06 | 101,793 | $4.54 | $461.94kSell |
CTMX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CTMX insiders and whales buy or sell their stock.
CTMX Shareholders
What type of owners hold Cytomx Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Kevin P. Starr | 2.39% | 5,201,767 | $14.15M | Insider |
| Timothy M. 1. Shannon | 2.09% | 4,563,247 | $12.41M | Insider |
| Robert I. Tepper | 2.00% | 4,349,864 | $11.83M | Insider |
| Canaan IX LP | 1.14% | 2,494,381 | $6.78M | Insider |
| Sean A. McCarthy | 0.61% | 1,330,817 | $3.62M | Insider |
| James E. Flynn | 0.43% | 946,024 | $2.57M | Insider |
| Hadley Harbor Master Investors Cayman LP | 0.34% | 749,055 | $2.04M | Insider |
| Frederick W. Gluck | 0.24% | 530,069 | $1.44M | Insider |
| Bvf Partners L P | 0.16% | 358,450 | $974.98k | Insider |
| Marcia Belvin | 0.14% | 300,760 | $818.07k | Insider |
CTMX vs Biotech Stocks
Cytomx Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.